Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

rhDNase as an example of recurrent event analysis.

Therneau TM, Hamilton SA.

Stat Med. 1997 Sep 30;16(18):2029-47.

PMID:
9308130
2.

rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.

Christopher F, Chase D, Stein K, Milne R.

J Clin Pharm Ther. 1999 Dec;24(6):415-26.

PMID:
10651974
4.
5.

Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.

Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.

Pediatr Pulmonol. 1998 Sep;26(3):155-61.

PMID:
9773909
6.

rhDNase in cystic fibrosis.

Tyrrell JC, Lewis PA, Sheldon CD, Connett G.

Thorax. 1999 Aug;54(8):752. No abstract available.

7.

The clinical use of rhDNAse.

Davies J, Trindale M, Wallis C, Rosenthal M, Bush A.

Pediatr Pulmonol Suppl. 1997;16:273-4. Review. No abstract available.

PMID:
9443309
8.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW; Pulmozyme Early Intervention Trial Study Group.

J Pediatr. 2001 Dec;139(6):813-20.

PMID:
11743506
10.

The use of recombinant human dornase alfa in CF.

Cox C.

Paediatr Nurs. 1995 Nov;7(9):29-31. Review. No abstract available.

PMID:
8705343
11.
12.

Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.

Spencer DA.

Thorax. 1997 Apr;52 Suppl 2:S89-91. Review. No abstract available.

13.

Aerosolized deoxyribonuclease for cystic fibrosis.

[No authors listed]

Med Lett Drugs Ther. 1994 Apr 15;36(920):34-5. No abstract available. Erratum in: Med Lett Drugs Ther 1994 May 27;36(923):48.

PMID:
8145672
14.

Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?

Conway SP.

Arch Dis Child. 1997 Jul;77(1):1-3. No abstract available.

15.

[Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].

Wizla-Derambure N, Michaud L, Sardet A, Deschildre A, Loeuille GA, Tassin E, Loire N, Buisine C, Boutry E, Dias J, Hecquet F, Turck D.

Arch Pediatr. 1998 Apr;5(4):378-83. French.

PMID:
9759156
16.

Evidence-based medicine.

Marino JT.

Pediatr Pulmonol. 1998 Sep;26(3):231-3. No abstract available.

PMID:
9773922
17.

Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.

Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, Mazzarella G, Raia V.

Arch Otolaryngol Head Neck Surg. 2005 Dec;131(12):1097-101.

PMID:
16365224
18.

Mucolytic therapy in cystic fibrosis.

Wallis C.

J R Soc Med. 2001;94 Suppl 40:17-24. Review. No abstract available.

19.

Consensus conference: practical applications of Pulmozyme. September 22, 1993.

Ramsey BW, Dorkin HL.

Pediatr Pulmonol. 1994 Jun;17(6):404-8. Review. No abstract available.

PMID:
8090614
20.

Supplemental Content

Support Center